Biotech China 2014

Oncology: Novartis Pharmaceuticals

Total Score People Score Events Score
46 32 31
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Target Validation by Chemical Probes/Designer Chemical Probes and Phenotypic Approach to Drug Discovery Chairperson: Michael A. Foley, Broad Institute of MIT and Harvard, Cambridge, MA John Tallarico
New Approaches to Drug Discovery Chairperson: William R. Sellers, Novartis Institutes for BioMedical Research, Cambridge, MA Eric Martin
December 4, 2012 4th World Epigenetics Summit Epigenetics - Impact for Translational and Drug Safety Sciences Remi Terranova
July 6, 2011 3rd WIN Symposium An example | Targeting the PI3K pathway - focused development for the treatment of cancer Samit Hirawat
May 19, 2010 Towards Personalized Cancer Medicine The Discovery and Application of Cancer Therapeutics in the Genomic Era William R Sellers
PANEL DISCUSSION William R Sellers
November 2, 2009 Track 1: Seventh Annual RNAi for Screening Cellular Pathways and Targets Using Targeted siRNA Screens to Identify Novel Regulators of Viral Replication Alex Gaither
Chairperson’s Remarks Alex Gaither
September 24, 2009 Track 2: Implementing Personalized Medicine : Inaugural Targeted Therapy Biomarkers - Driven Drug and Diagnostic Co-Development in Oncology: Current Trends and Future Approaches Miro Venturi
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Challenges for Interim Data Monitoring and Decision Making in Confirmatory Adaptive Trials Paul Gallo
Evaluating Adaptive and Model-Based Approaches for Dose-Ranging Studies: An Update with Recommendations from the PhRMA Working Group Jose Pinheiro
June 10, 2009 Inaugural Risk Management and Drug Safety Strategies for Better Decision Making Risk Mitigation Strategy for Cardiotox: A Case Study in Oncology Bérengère Dumotier
April 7, 2009 Kinase Inhibitor Chemistry - Charting the Chemical Space Iterative Kinase Medium-Throughput Screening with 2D profile-QSAR and 3D AutoShim Models Eric Martin
February 10, 2009 10th Annual Phase I Clinical Trials Novartis case study on optimising clinical trial design Frank Bretz
Selecting the correct starting dose for FIM antibody studies Peter Lloyd
January 26, 2009 Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
January 26, 2009 Biomarker Assay Development Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
Opportunities and Challenges of Biomarker Assays in Drug Development Francois Legay
Target-Related Pharmacodynamic Analysis to Guide Successful Development of Biological Therapies: Novel Biomarker Concepts and Analytical Strategies Miro Venturi
January 26, 2009 Translational Cancer Medicine Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
TRANSLATIONAL IMAGING : Translational Molecular Imaging: Oncology Syed Mahmood
January 26, 2009 7th Annual Partnering with Central Labs B2 : The Use of Imaging Biomarkers in Phase I/II trials Haren Rupani
Technical Hot Topics Haren Rupani
Track A : Improve Patient Care, Transparency and Process Efficiency in Global Studies Scott Sawicki
Track A : Central Lab Cost Drivers and Logistics Discussion Forum Scott Sawicki
January 5, 2009 High Content Analysis High-Content Screen to Look for Inhibitors of Virus Entry Marjo Simonen
Evaluation of Data Analysis Tools for the Multivariate Classification of Compound Responses Detected by High-Content Screening Anne Kuemmel
November 17, 2008 BIO-Europe 2008 What Buyers Want: Understanding What Big Pharma Expect to See in Out-Licensing Documents Axel Maibuecher
October 22, 2008 HDAC Inhibitors: Targeting Oncology and Beyond Chairperson’s Remarks Peter Atadja
Development of the Pan-DAC Inhibitor Panobinostat (LBH589) in Anti-Cancer Therapy Peter Atadja
September 29, 2008 Genomic Biomarkers Biomarker Application in Oncology Clinical Development Michael Shi
September 19, 2008 Clinical Trials Workshop Planning Committee John A Hohneker
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Harmonization of International Standards for Oncology Products Daniel Lapadula
Panel Discussion Daniel Lapadula
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Keynote Address: Chinese SFDA and Global Drug Development - Quality, Science and Speed Paul Dai
March 31, 2008 China 2008 Pharmaceutical R&D Summit Leveraging Traditional Chinese Medical Knowledge for Modern Medicine: Collaborating with the Shanghai Institute of Materia Medica Paul Herrling
Global Pharma Exchange Roundtable En Li
Track II Clinical Research Development in China – Experiences, Improvements and Changes Chairperson’s Opening Remarks Paul Dai
March 25, 2008 PATHWAY ANALYSIS Predictive Value of in Vitro Safety Studies Willi Suter
Integrating High-Throughput Data via Pathway-Centric Analyses Joseph D Szustakowski
March 25, 2008 Clinical Trials Asia Accelerate Oncology Clinical Development in Asia Michael Shi
March 25, 2008 Preclinical Development Mechanistic Cardiac Modeling: Concepts and Utility in Drug Development Anna Georgieva
Predictive Value of in Vitro Safety Studies Willi Suter
Imaging in Phase II/III Clinical Development Haren Rupani
March 25, 2008 TRANSLATIONAL MEDICINE Imaging in Phase II/III Clinical Development Haren Rupani
March 25, 2008 CANCER MOLECULAR MARKERS Predictive Value of in Vitro Safety Studies Willi Suter
March 25, 2008 TRENDS IN DRUG SAFETY Mechanistic Cardiac Modeling: Concepts and Utility in Drug Development Anna Georgieva
Predictive Value of in Vitro Safety Studies Willi Suter
February 19, 2008 Screening Europe Track A Modern Approaches for an Old Problem: High-Throughput Screening and Compound Profiling of Proteases Lorenz Mayr
Track B Emerging GPCR Assay Technologies for Drug Discovery Sandra Siehler
October 26, 2007 Clinical Trials Workshop General Session: The Role of the Oncology Team (Part 1) John A Hohneker
October 16, 2007 Second Annual Putting Theory into Practice: Adaptive Clinical Trial Designs (Oct 16-17 SESSION I: LAYING THE GROUND WORK FOR EARLY DECISION MAKING (13:45 - 19:00) Jose Pinheiro
SESSION I: Evaluating Adaptive Dose-Ranging Studies: Conclusions and Recommendations from the PhRMA Working Group (16:00 - 16:30) Jose Pinheiro
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.